Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

HLA class II susceptibility to cervical cancer among Tunisian women.

Ben Othmane Y, Ghazouani E, Mezlini A, Lagha A, Raïs M, Kochkar R, Zidi S, Afrit M, Mota-Vieira L, Yacoubi Loueslati B.

Bull Cancer. 2012 Sep;99(9):81-6. doi: 10.1684/bdc.2012.1623.

2.

Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.

Hu JM, Sun Q, Li L, Liu CX, Chen YZ, Zou H, Pang LJ, Zhao J, Yang L, Cao YW, Cui XB, Qi Y, Liang WH, Zhang WJ, Li F.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6165-71. eCollection 2014.

3.

HLA-DRB1*1501 and HLA-DQB1*0301 alleles are positively associated with HPV16 infection-related Kazakh esophageal squamous cell carcinoma in Xinjiang China.

Hu J, Li L, Pang L, Chen Y, Yang L, Liu C, Zhao J, Chang B, Qi Y, Liang W, Li F.

Cancer Immunol Immunother. 2012 Nov;61(11):2135-41. doi: 10.1007/s00262-012-1281-x. Epub 2012 May 16.

PMID:
22588649
4.

Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.

Hernández-Hernández DM, Cerda-Flores RM, Juárez-Cedillo T, Granados-Arriola J, Vargas-Alarcón G, Apresa-García T, Alvarado-Cabrero I, García-Carrancá A, Salcedo-Vargas M, Mohar-Betancourt A.

Int J Gynecol Cancer. 2009 Aug;19(6):1099-106. doi: 10.1111/IGC.0b013e3181a83cf4.

PMID:
19820376
5.

Human leukocyte antigen class II and cervical cancer risk: a population-based study.

Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, Nelson JL, Porter P, Shera KA, McDougall JK, Galloway DA.

J Infect Dis. 2002 Dec 1;186(11):1565-74. Epub 2002 Nov 4.

PMID:
12447731
6.

Human leukocyte antigen class II alleles and risk of cervical cancer in China.

Wu Y, Liu B, Lin W, Xu Y, Li L, Zhang Y, Chen S, Lin Z, Xu A.

Hum Immunol. 2007 Mar;68(3):192-200. Epub 2006 Aug 7.

PMID:
17349874
7.

Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.

Kohaar I, Hussain S, Thakur N, Tiwari P, Nasare V, Batra S, Singh V, Bhambani S, Das BC, Sarkar DP, Bharadwaj M.

Hum Immunol. 2009 Apr;70(4):222-9. doi: 10.1016/j.humimm.2009.01.003. Epub 2009 Jan 18.

PMID:
19272325
8.

Association of HLA-DR/DQ polymorphisms with Guillain-Barré syndrome in Tunisian patients.

Fekih-Mrissa N, Mrad M, Riahi A, Sayeh A, Zaouali J, Gritli N, Mrissa R.

Clin Neurol Neurosurg. 2014 Jun;121:19-22. doi: 10.1016/j.clineuro.2014.03.014. Epub 2014 Mar 19.

PMID:
24793468
9.

Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.

Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1183-91.

10.

Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.

Gokhale P, Kerkar S, Tongaonkar H, Chaudhari H, Warke H, Salvi V, Mania-Pramanik J.

Indian J Med Res. 2014 Nov;140 Suppl:S36-43.

11.

Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, Li S, Zhao LP, Daling JR, Schwartz SM, Galloway DA.

Cancer Res. 2008 May 1;68(9):3532-9. doi: 10.1158/0008-5472.CAN-07-6471.

12.

Association of DRB1 and DQB1 HLA class II polymorphisms in high-grade and neoplastic cervical lesions of women from Argentina.

Eiguchi K, Tatti S, Alonio LV, González JV, Leirós GJ, Fleider L, Vighi S, Padros K, Raimondi E, Teyssié A, Picconi MA.

J Low Genit Tract Dis. 2008 Oct;12(4):262-8. doi: 10.1097/LGT.0b013e3181729285.

PMID:
18820539
13.

Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma.

Apple RJ, Becker TM, Wheeler CM, Erlich HA.

J Natl Cancer Inst. 1995 Mar 15;87(6):427-36.

PMID:
7861462
14.

Association of HLA-DR-DQ polymorphisms with diabetes in Tunisian patients.

Fekih Mrissa N, Mrad M, Ouertani H, Baatour M, Sayeh A, Nsiri B, Lamine K, Zidi B, Gritli N.

Transfus Apher Sci. 2013 Oct;49(2):200-4. doi: 10.1016/j.transci.2013.01.012. Epub 2013 Feb 9.

PMID:
23402837
15.

Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients.

Sayeh A, Cheikh CB, Mrad M, Lakhal N, Gritli N, Galelli S, Oumaya A, Fekih-Mrissa N.

Ann Saudi Med. 2014 Nov-Dec;34(6):503-7. doi: 10.5144/0256-4947.2014.503.

16.

Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.

Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M; Shinshu PBC Study Group.

Hepatology. 2012 Feb;55(2):506-11. doi: 10.1002/hep.24705. Epub 2011 Dec 19.

PMID:
21953406
17.

Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.

Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1035-41.

18.

HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women.

Lin P, Koutsky LA, Critchlow CW, Apple RJ, Hawes SE, Hughes JP, Touré P, Dembele A, Kiviat NB.

Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1037-45.

19.
20.

Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia.

Stayoussef M, Benmansour J, Al-Irhayim AQ, Said HB, Rayana CB, Mahjoub T, Almawi WY.

Clin Vaccine Immunol. 2009 Aug;16(8):1146-50. doi: 10.1128/CVI.00105-09. Epub 2009 Jun 24.

Supplemental Content

Support Center